Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Published:2024-05-20 Issue:10 Volume:16 Page:8772-8809
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Liu Yong¹,Zhang Xiangwei²,Pang Zhaofei³,Wang Yadong¹,Zheng Haotian¹,Wang Guanghui²⁴,Wang Kai¹,Du Jiajun²⁴

Affiliation:

1. Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan 250021, Shandong, China

2. Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China

3. Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China

4. Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China

Publisher

Impact Journals, LLC

Reference73 articles.

1. Cancer statistics, 2023.;Jemal;CA Cancer J Clin,2023

2. Spectrum of Lung Adenocarcinoma.;Ko;Semin Ultrasound CT MR,2019

3. Lung cancer: current therapies and new targeted treatments.;Paz-Ares;Lancet,2017

4. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.;Brown;Nat Med,2018

5. Understanding the Intersections between Metabolism and Cancer Biology.;DeBerardinis;Cell,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP